HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
New Zealand Labour Backs Social Media Ban for Under-16s 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Faraday Future Delivers First Robots in Middle East, Plans September Launches 
Nvidia Options Price in $280 Billion Earnings Swing 
U.S. Disrupts China-Linked Hacking Campaign Targeting Government Agencies 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Unitree Shares Plunge 45% After Blockbuster IPO, Raising China Tech Bubble Fears 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
Add as a preferred source on Google
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
